Table 2.
CON | MIE | HIE | |
---|---|---|---|
Baseline FMD | |||
Pre-occlusion diameter (mm) | 4.11 ± 0.24 | 4.02 ± 0.24 | 3.98 ± 0.24 |
Post-occlusion Peak diameter (mm) | 4.35 ± 0.23 | 4.31 ± 0.23 | 4.28 ± 0.23 |
Post-Exercise/Pre-OGTT | |||
Pre-occlusion diameter (mm) | 4.05 ± 0.23 | 4.00 ± 0.25 | 4.15 ± 0.25 |
Post-occlusion Peak diameter (mm) | 4.37 ± 0.25 | 4.26 ± 0.22 | 4.38 ± 0.24 |
1 hr OGTT | |||
Pre-occlusion diameter (mm) | 3.94 ± 0.23 | 4.03 ± 0.27 | 4.03 ± 0.25 |
Post-occlusion Peak diameter (mm) | 4.29 ± 0.25 | 4.33 ± 0.26 | 4.36 ± 0.26 |
2 hr OGTT | |||
Pre-occlusion diameter (mm) | 4.13 ± 0.24 | 4.05 ± 0.26 | 4.05 ± 0.23 |
Post-occlusion Peak diameter (mm) | 4.43 ± 0.24 | 4.38 ± 0.24 | 4.34 ± 0.24 |
Data are expressed as mean ± SEM. Conditions were compared by repeated measures analysis of variance (ANOVA). CON = control. MIE = moderate intensity exercise. HIE = high intensity exercise. OGTT = oral glucose tolerance test. No statistical differences within or between conditions were observed.